Selected research
Industry Research
Hydroxychloroquine Sulfate Tablets Industry Research Report 2026
Market perspective
The global Hydroxychloroquine Sulfate Tablets market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Hydroxychloroquine Sulfate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Hydroxychloroquine Sulfate Tablets is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Hydroxychloroquine Sulfate Tablets is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Hydroxychloroquine Sulfate Tablets include Cinkate Corporation, Concordia Healthcare, Hikma Pharmaceuticals, Ipca Laboratories, Taj Pharmaceuticals Limited, Mylan, Novartis, Sanofi and Shanghai Pharmaceuticals Holding Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Hydroxychloroquine Sulfate Tablets market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Hydroxychloroquine Sulfate Tablets Market by Company
Cinkate Corporation
Concordia Healthcare
Hikma Pharmaceuticals
Ipca Laboratories
Taj Pharmaceuticals Limited
Mylan
Novartis
Sanofi
Shanghai Pharmaceuticals Holding Co., Ltd.
Teva Pharmaceutical Industries Ltd.
Hydroxychloroquine Sulfate Tablets Segment by Type
100 mg
200 mg
Hydroxychloroquine Sulfate Tablets Segment by Application
Hospital
Pharmacy
Other
Hydroxychloroquine Sulfate Tablets Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hydroxychloroquine Sulfate Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hydroxychloroquine Sulfate Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hydroxychloroquine Sulfate Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Hydroxychloroquine Sulfate Tablets manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Hydroxychloroquine Sulfate Tablets by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Hydroxychloroquine Sulfate Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 100 mg
- 200 mg
Applications
- Hospital
- Pharmacy
- Other
Companies covered
- Cinkate Corporation
- Concordia Healthcare
- Hikma Pharmaceuticals
- Ipca Laboratories
- Taj Pharmaceuticals Limited
- Mylan
- Novartis
- Sanofi
- Shanghai Pharmaceuticals Holding Co., Ltd.
- Teva Pharmaceutical Industries Ltd.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Hydroxychloroquine Sulfate Tablets Market Size (2021-2032)
- 2.2.2 Global Hydroxychloroquine Sulfate Tablets Sales (2021-2032)
- 2.2.3 Global Hydroxychloroquine Sulfate Tablets Market Average Price (2021-2032)
- 2.3 Hydroxychloroquine Sulfate Tablets by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 100 mg
- 2.3.3 200 mg
- 2.4 Hydroxychloroquine Sulfate Tablets by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Pharmacy
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Hydroxychloroquine Sulfate Tablets Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Hydroxychloroquine Sulfate Tablets Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Hydroxychloroquine Sulfate Tablets Revenue of Manufacturers (2021-2026)
- 3.4 Global Hydroxychloroquine Sulfate Tablets Average Price by Manufacturers (2021-2026)
- 3.5 Global Hydroxychloroquine Sulfate Tablets Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Hydroxychloroquine Sulfate Tablets, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Hydroxychloroquine Sulfate Tablets, Product Type & Application
- 3.8 Global Manufacturers of Hydroxychloroquine Sulfate Tablets, Established Date
- 3.9 Global Hydroxychloroquine Sulfate Tablets Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Cinkate Corporation
- 4.1.1 Cinkate Corporation Company Information
- 4.1.2 Cinkate Corporation Business Overview
- 4.1.3 Cinkate Corporation Hydroxychloroquine Sulfate Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Cinkate Corporation Hydroxychloroquine Sulfate Tablets Product Portfolio
- 4.1.5 Cinkate Corporation Recent Developments
- 4.2 Concordia Healthcare
- 4.2.1 Concordia Healthcare Company Information
- 4.2.2 Concordia Healthcare Business Overview
- 4.2.3 Concordia Healthcare Hydroxychloroquine Sulfate Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Concordia Healthcare Hydroxychloroquine Sulfate Tablets Product Portfolio
- 4.2.5 Concordia Healthcare Recent Developments
- 4.3 Hikma Pharmaceuticals
- 4.3.1 Hikma Pharmaceuticals Company Information
- 4.3.2 Hikma Pharmaceuticals Business Overview
- 4.3.3 Hikma Pharmaceuticals Hydroxychloroquine Sulfate Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Hikma Pharmaceuticals Hydroxychloroquine Sulfate Tablets Product Portfolio
- 4.3.5 Hikma Pharmaceuticals Recent Developments
- 4.4 Ipca Laboratories
- 4.4.1 Ipca Laboratories Company Information
- 4.4.2 Ipca Laboratories Business Overview
- 4.4.3 Ipca Laboratories Hydroxychloroquine Sulfate Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Ipca Laboratories Hydroxychloroquine Sulfate Tablets Product Portfolio
- 4.4.5 Ipca Laboratories Recent Developments
- 4.5 Taj Pharmaceuticals Limited
- 4.5.1 Taj Pharmaceuticals Limited Company Information
- 4.5.2 Taj Pharmaceuticals Limited Business Overview
- 4.5.3 Taj Pharmaceuticals Limited Hydroxychloroquine Sulfate Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Taj Pharmaceuticals Limited Hydroxychloroquine Sulfate Tablets Product Portfolio
- 4.5.5 Taj Pharmaceuticals Limited Recent Developments
- 4.6 Mylan
- 4.6.1 Mylan Company Information
- 4.6.2 Mylan Business Overview
- 4.6.3 Mylan Hydroxychloroquine Sulfate Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Mylan Hydroxychloroquine Sulfate Tablets Product Portfolio
- 4.6.5 Mylan Recent Developments
- 4.7 Novartis
- 4.7.1 Novartis Company Information
- 4.7.2 Novartis Business Overview
- 4.7.3 Novartis Hydroxychloroquine Sulfate Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Novartis Hydroxychloroquine Sulfate Tablets Product Portfolio
- 4.7.5 Novartis Recent Developments
- 4.8 Sanofi
- 4.8.1 Sanofi Company Information
- 4.8.2 Sanofi Business Overview
- 4.8.3 Sanofi Hydroxychloroquine Sulfate Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Sanofi Hydroxychloroquine Sulfate Tablets Product Portfolio
- 4.8.5 Sanofi Recent Developments
- 4.9 Shanghai Pharmaceuticals Holding Co., Ltd.
- 4.9.1 Shanghai Pharmaceuticals Holding Co., Ltd. Company Information
- 4.9.2 Shanghai Pharmaceuticals Holding Co., Ltd. Business Overview
- 4.9.3 Shanghai Pharmaceuticals Holding Co., Ltd. Hydroxychloroquine Sulfate Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Shanghai Pharmaceuticals Holding Co., Ltd. Hydroxychloroquine Sulfate Tablets Product Portfolio
- 4.9.5 Shanghai Pharmaceuticals Holding Co., Ltd. Recent Developments
- 4.10 Teva Pharmaceutical Industries Ltd.
- 4.10.1 Teva Pharmaceutical Industries Ltd. Company Information
- 4.10.2 Teva Pharmaceutical Industries Ltd. Business Overview
- 4.10.3 Teva Pharmaceutical Industries Ltd. Hydroxychloroquine Sulfate Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Teva Pharmaceutical Industries Ltd. Hydroxychloroquine Sulfate Tablets Product Portfolio
- 4.10.5 Teva Pharmaceutical Industries Ltd. Recent Developments
5 Global Hydroxychloroquine Sulfate Tablets Market Scenario by Region
- 5.1 Global Hydroxychloroquine Sulfate Tablets Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Hydroxychloroquine Sulfate Tablets Sales by Region: 2021-2032
- 5.2.1 Global Hydroxychloroquine Sulfate Tablets Sales by Region: 2021-2026
- 5.2.2 Global Hydroxychloroquine Sulfate Tablets Sales by Region: 2027-2032
- 5.3 Global Hydroxychloroquine Sulfate Tablets Revenue by Region: 2021-2032
- 5.3.1 Global Hydroxychloroquine Sulfate Tablets Revenue by Region: 2021-2026
- 5.3.2 Global Hydroxychloroquine Sulfate Tablets Revenue by Region: 2027-2032
- 5.4 North America Hydroxychloroquine Sulfate Tablets Market Facts & Figures by Country
- 5.4.1 North America Hydroxychloroquine Sulfate Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Hydroxychloroquine Sulfate Tablets Sales by Country (2021-2032)
- 5.4.3 North America Hydroxychloroquine Sulfate Tablets Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Hydroxychloroquine Sulfate Tablets Market Facts & Figures by Country
- 5.5.1 Europe Hydroxychloroquine Sulfate Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Hydroxychloroquine Sulfate Tablets Sales by Country (2021-2032)
- 5.5.3 Europe Hydroxychloroquine Sulfate Tablets Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Hydroxychloroquine Sulfate Tablets Market Facts & Figures by Country
- 5.6.1 Asia Pacific Hydroxychloroquine Sulfate Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Hydroxychloroquine Sulfate Tablets Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Hydroxychloroquine Sulfate Tablets Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Hydroxychloroquine Sulfate Tablets Market Facts & Figures by Country
- 5.7.1 South America Hydroxychloroquine Sulfate Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Hydroxychloroquine Sulfate Tablets Sales by Country (2021-2032)
- 5.7.3 South America Hydroxychloroquine Sulfate Tablets Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Hydroxychloroquine Sulfate Tablets Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Hydroxychloroquine Sulfate Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Hydroxychloroquine Sulfate Tablets Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Hydroxychloroquine Sulfate Tablets Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Hydroxychloroquine Sulfate Tablets Sales by Type (2021-2032)
- 6.1.1 Global Hydroxychloroquine Sulfate Tablets Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Hydroxychloroquine Sulfate Tablets Sales Market Share by Type (2021-2032)
- 6.2 Global Hydroxychloroquine Sulfate Tablets Revenue by Type (2021-2032)
- 6.2.1 Global Hydroxychloroquine Sulfate Tablets Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Hydroxychloroquine Sulfate Tablets Revenue Market Share by Type (2021-2032)
- 6.3 Global Hydroxychloroquine Sulfate Tablets Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Hydroxychloroquine Sulfate Tablets Sales by Application (2021-2032)
- 7.1.1 Global Hydroxychloroquine Sulfate Tablets Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Hydroxychloroquine Sulfate Tablets Sales Market Share by Application (2021-2032)
- 7.2 Global Hydroxychloroquine Sulfate Tablets Revenue by Application (2021-2032)
- 7.2.1 Global Hydroxychloroquine Sulfate Tablets Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Hydroxychloroquine Sulfate Tablets Revenue Market Share by Application (2021-2032)
- 7.3 Global Hydroxychloroquine Sulfate Tablets Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Hydroxychloroquine Sulfate Tablets Value Chain Analysis
- 8.1.1 Hydroxychloroquine Sulfate Tablets Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Hydroxychloroquine Sulfate Tablets Production Mode & Process
- 8.2 Hydroxychloroquine Sulfate Tablets Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Hydroxychloroquine Sulfate Tablets Distributors
- 8.2.3 Hydroxychloroquine Sulfate Tablets Customers
9 Global Hydroxychloroquine Sulfate Tablets Analyzing Market Dynamics
- 9.1 Hydroxychloroquine Sulfate Tablets Industry Trends
- 9.2 Hydroxychloroquine Sulfate Tablets Industry Drivers
- 9.3 Hydroxychloroquine Sulfate Tablets Industry Opportunities and Challenges
- 9.4 Hydroxychloroquine Sulfate Tablets Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst